“…CM-H 2 DCFDA is a non-fluorescent molecule (DCFH) that, when taken up by cells, is rapidly oxidized to a diagnosis and therapy. 47,[95][96][97] For example, new fluorescent probes have been developed to visualize xenografted tumors, based on their ability to produce hydrogen peroxide. 98 Similarly, human breast and lung cancer patients can be positively identified by examining their exhaled breath for the presence of hydrogen peroxide.…”